We evaluated the previously reported association between lipid-lowering drugs and the risk of cataracts17,18 but observed no significant signal for PCSK9, APOB, or LDLR and any of the six tested phecodes pertinent to cataracts. The gene discussed is APOB; the disease is cataract.